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SUMMARY 
Monoclonal antibodies were raised against differentiated cells, and blastema! cells from 
regenerating limbs of adult newts (Notophthalmus viridescens) and screened for specific staining 
by immunocytochemistry. In addition to antibodies that identify muscle, Schwann cells and 
cartilage, two reagents were specific for subpopulations of blastema! cells. One of these latter 
antibodies, termed 22/18, has provided new evidence about the origin of blastema! cells from 
Schwann cells and myofibres, and also identifies blastema! cells whose division is persistently 
dependent on the nerve supply. 
INTRODUCTION 
Amputation of the limb in Urodele amphibians is followed by formation of a 
blastema, a growth zone composed of undifferentiated cells. The cells of the 
blastema are unusual in that they appear to originate from differentiated tissue 
after amputation, a process referred to as dedifferentiation, yet in many respects 
they are similar to embryonic progenitor cells. They are capable of extensive 
division during the early period of blastema! growth, apparently in response to a 
stimulus from the nerve supply, and they subsequently give rise to the various cell 
types that make up the internal tissue of the regenerate (for a review of limb 
regeneration see Wallace, 1981). 
The classical anatomical descriptions of limb regeneration have emphasized that 
blastema! cells are indistinguishable by morphological criteria from the time that 
they arise until the onset of terminal differentiation (Thornton, 1938; Chalkley, 
1954; Salpeter & Singer, 1960; Hay, 1962, among others) although some recent 
attempts have been made to make such distinctions (Geraudie & Singer, 1981). 
Despite this apparent homogeneity, it is possible that blastema! cells comprise a 
progenitor population of several different cell types and that such heterogeneity is 
reflected by molecular rather than morphological differences. There are several 
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possible sources of heterogeneity within this population including the cell type 
from which blastema! cells are derived (Chalkley, 1954) and their location with 
respect to positional cues (French, Bryant & Bryant, 1976). The identification of 
such non-equivalent sets would be an important step towards analysing the cellular 
composition of the blastema. 
In many systems, the analysis of cell heterogeneity and its relation to cell 
function has depended on cell markers. Much of the progress in cellular immu-
nology, for example, reflects the use of antibodies that allow identification 
and manipulation of different classes of lymphocytes (Mishell & Shiigi, 1980). In 
the case of limb regeneration, we have begun by isolating markers that distinguish 
between blastema! cells and the various differentiated cell types, or ones that 
distinguish between blastema! cells themselves. These markers have been 
obtained by generating monoclonal antibodies against differentiated tissue and 
blastema! tissue from the limbs of adult newts (Notophthalmus viridescens). The 
antibodies were screened by indirect immunofluorescence of tissue sections of 
regenerating limbs in order to detect reagents that were cell specific. Several 
markers for myelin, myofibres, and cartilage were defined. In addition, two 
antibodies were obtained that distinguish between blastema! cells and reveal a 
change in the cellular composition of the blastema with time after amputation. 
One of these reagents, 22/18, has been used in conjunction with markers for 
differentiated tissue to obtain new evidence about the origin of some blastema! 
cells from muscle fibres and Schwann cells. Furthermore, 22/18 identifies cells 
whose division is persistently dependent on the nerve supply, even in the later 
stage of regeneration. 
MATERIALS AND METHODS 
Animals 
Adult newts, Notophthalmus viridescens, from Lee's Newt Farm, Tennessee were maintained 
in the laboratory at 20-23 oc and fed dried Tubifex worms twice weekly. Operations were 
performed on animals anaesthetized with 0·1 % Tricane. Forelimbs were amputated by cutting 
the limb just below the elbow, pushing the soft tissue down the bone, cutting the bone and then 
trimming the soft tissue to produce a fiat amputation surface. The stage of regeneration was 
judged according to the classification of Iten & Bryant (1973). 
Tissue preparation for immunization 
Various tissues were dissected from adult newts for use as immunogen and stored at -80°C. 
Muscle was taken from forelimbs, cartilage from epiphyses of forelimb bones, and blastema! 
tissue from early to midbud-stage forelimb regenerates. Crude homogenates were prepared 
from muscle and cartilage by homogenizing 1 gm wet-weight tissue in a Dounce homogenizer 
with 10 strokes in 10vols phosphate-buffered saline (PBS:0·15M-NaCl, 0·05M-sodium phos-
phate, pH7·2), followed by centrifugation at 700g for 15min to remove large debri. A crude 
membrane pellet was prepared from medium-bud blastemas by homogenizing 0·5 gm, wet-
weight (approx. 200 blastemas) tissue in 0·32M-sucrose, 5mM-sodium phosphate, pH7·4 and 
1 mM-phenylmethylsulphonyl fluoride (Buffer A), followed by centrifugation of the crude 
homogenate at 11 000 g for 60 min. The pellet was washed once in buffer A and resuspended in 
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PBS. Myelin was prepared from homogenized peripheral nerves by centrifugation through a 
discontinuous sucrose gradient as described previously (Fryxell, Balzer & Brockes, 1983). 
An alternative preparation of blastema} tissue for immunization was to prepare a crude 
membrane fraction from mechanically dissociated blastema} cells. Blastemas were removed 
from early- to medium-bud regenerates and mechanically dissociated by gently shearing in a 
loose-fitting glass homogenizer in Hepes-buffered saline (HBS: 120 mM-NaCI, 3 mM-KCI, 
0·01 mM-CaC12, 5 mM-Hepes, pH7·2). Dissociated cells were filtered through nylon mesh to 
remove the undissociated epidermis and sedimented at 400 g for 10 min at 20 oc through a 
discontinuous gradient consisting of layers of 20%, 15%, 10% and 5% Ficoll in HBS. Cells 
were collected from the 15 % and 10 % layers and interface, washed once in HBS and stored at 
-70°C. Crude membranes were prepared from dissociated cells as described above for tissue 
sources. 
Immunization 
Balb/c female mice were primed (50-100 micrograms protein/mouse) with an emulsion of 
Freund's complete adjuvant and either crude homogenates, crude membrane fractions from 
tissue or crude membrane fractions from dissociated cells. Two weeks later, mice were boosted 
with the same material emulsified in Freund's incomplete adjuvant. After at least two weeks, 
mice were boosted by intraperitoneal injections on 4, 3 and 2 days before being sacrificed for the 
production of hybridomas. 
Production of monoclonal antibodies 
Hybridomas were generated from spleen cells of immunized mice by polyethylene glycol 
mediated fusion to a myeloma cell line, NS-1, using essentially the method of Kohler & Milstein 
(1975) as described previously (Moore, Fritz, Raftery & Brockes, 1982). Hybridoma clones were 
first screened for antibody secretion using a solid-phase, enzyme-linked, immunosorbent assay 
(Engvall & Perlmann, 1972). Antibody-secreting clones were tested by indirect immuno-
fluorescence on frozen tissue sections of regenerating limbs as described below. Hybridoma 
clones that showed noteworthy specificity were cloned several times by limiting dilution and 
used to produce high titre fluids from ascites tumours. 
Immunohistochemistry 
22/31 and 22/18 antibodies (both IgM) were purified from ascites fluids by exclusion 
chromatography on AcA 34 (LKB) in PBS, 0·1% sodium azide. Protein in the void volume was 
pooled, dialysed against PBS, 0·1% sodium azide and stored in aliquots at 1·0mgml-1 at 
-70°C. 22/31 antibody was biotinylated using biotin succinimide ester (BSE, Sigma) by 
standard techniques. In brief, a 1·0 mg ml-1 solution of BSE in dimethyl sulphoxide was mixed 
in varying ratios (1: 4 to 1:16, biotin: protein) with a 1·0 mg ml- 1 solution of purified antibody in 
0·1 M-NaHC03, pH 8 ·4. After reacting at room temperature for 4 h, unconjugated biotin was 
removed by dialysis overnight against PBS, 0·1% sodium azide. The optimal ratio of biotin to 
protein was determined by testing biotinylated antibodies on tissue sections in indirect 
immunofluorescence using fluoresceinated avidin as the final layer. Rhodamine and fluorescein 
conjugates were absorbed on bovine liver powder to remove high background staining of 
epidermis on tissue sections. 
Tissue sections were prepared from forelimbs fixed by immersion at 4 oc for 45 min in 0·01 M-
sodium periodate, 0·1 M-lysine-HCI, 0·05% paraformaldehyde (McLean & Nakene, 1974) in 
HBS followed by a 15 min wash in HBS. Frozen sections of 10 f..tm were cut from fixed tissue with 
a cryostat, mounted on coverslips subbed with Gatenby's solution, air-dried, and stored at 
-70°C. In some experiments tissue sections were prepared from mature limbs fixed by freeze-
substitution (Gurdon, Partington & De Robertis, 1974) and embedded in methacrylate as 
described by Jamrich, Mahon, Gavis & Gall (1984). One micron sections cut on a glass knife 
were dried onto subbed slides and stored at room temp. Before staining with antibody, 
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methacrylate sections were passed through xylene, 100% ethanol, and decreasing ethanol 
concentrations into PBS. This procedure was not suitable when sections were stained with 22/18 
since it gave severe loss of antigenicity. 
Sections were stained with both 22/31 and 22/18 antibodies by exposing them seguentially to 
22/18 (1:200), rabbit-anti-mouse lgM (Mu chain specific, Miles, 1: 200), 22/18 (1: 200), 
biotinylated 22/31 (1:100) and finally rhodamine-conjugated goat-anti-rabbit lgG (Cappel, 
1: 100) and fluorescein-conjugated avidin (Vector lab, 1: 1000). In this protocol, the sections 
were reacted a second time with 22/18 in order to saturate any unreacted antigen combining 
sites on the rabbit-anti-mouse lgM bound in the second layer. Tissue sections were stained with 
both the 22/18 and 12/101 antibodies by exposing them sequentially to 22/18 (1: 200) and 12/101 
(lgG) (1:100), rabbit-anti-mouse lgM (Mu chain specific, Miles, 1: 100), and then to rhodamine-
conjugated goat-anti-rabbit lgG (Cappel, 1: 100) and fluorescein-conjugated goat-anti-mouse 
lgG (gamma chain specific, Cappel, 1: 50). The same protocol was used to stain with 22/18 and 
the myelin Po protein by substituting 12/101 with 30/3,30/14 and 30/26 (lgG, all diluted 1: 100). 
All layers were incubated for 45 min at room temp. and followed by three washes with PBS, 
0·1 % sodium azide with the exception of incubations using fluoresceinated avidin which were 
for 10-15 min to reduce background staining. After the last layer, sections were postfixed in acid 
alcohol (95% ethanol: 5% acetic acid), neutralized, counterstained with 0·5 J.tgml- 1 solution of 
Hoechst 33258 in PBS to detect nuclei, desalted by dipping in distilled water and mounted 
in 90% glycerol, 10% PBS, 2·0 %, 1,4 diazabicycol2.2.2 octane, pH8·0. Control experiments 
in which monoclonal antibodies were omitted or non-specific monoclonal antibodies were 
substituted gave low-background staining except occasionally on the epidermis. 
Sections were viewed and photographed under a Zeiss photomicroscope III equipped with 
Nomarski optics, epifluorescence and filter systems to separate Hoechst dye, fluorescein, and 
rhodamine fluorescence. Photographs were taken on Kodak Ektachrome film (ASA 400) with 
manually determined exposure periods. 
Labelling index of 22 I 18+ and 22 I 18- cells in denervated versus innervated blastemas 
Animals were bilaterally amputated and then denervated on one side by cutting the spinal 
nerves at the level ofthe brachial plexus at either 10 days (early bud, four animals) or 20-25 days 
(late bud-palette, eight animals) after amputation. Two days after denervation, animals were 
injected intraperitoneally with 25 ,uCi [3H]thymidine (Amersham, 86 Ci mMole-1) in 0·05 ml 
HBS. 24 h after injection of label, the innervated and denervated forelimbs were removed, fixed 
in periodate-lysine as described above, mounted together in embedding medium and sectioned 
transversely. Five to eight sections from several different levels of the blastemas were collected 
onto subbed slides. Sections were stained with 22/18 and with Hoechst dye as described above. 
For autoradiography, slides were desalted, dried and dipped in liquid emulsion (liford, K5 
diluted 1:1 in water), dried and stored at 4°C. After 3-4 days, the slides were developed in 019 
(Kodak, diluted 1:1 in water) for 3 min, stopped in 20% acetic acid for 0·5 min, fixed in Hypam 
fixer (liford, diluted 1:4 in water), washed in distilled water for 15 min, and then dried and 
mounted as above. 
RESULTS 
Antibody production 
Table 1lists the properties of several hybridomas that were obtained from mice 
immunized with differentiated tissue. Fig. 1 shows examples of staining a mature 
newt limb with a myofibre antibody, 121101 (Fig. 1A,B) and with an antibody for 
myelinating Schwann cells, 30126 (Fig. 1C,D). In each case, it was relatively easy 
to obtain markers that were specific for a differentiated cell type since monoclonal 
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antibodies derived from mice immunized with differentiated tissue usually in-
cluded several that appeared to show specific staining. This result probably reflects 
the high abundance of cell-specific molecules in differentiated tissue. For example, 
the monoclonal antibodies against myelin (30/3, 30/14, 30/26 in Table 1) were 
found by Western blotting analysis to be directed against the major myelin 
glycoprotein, Po, which accounts for over 50% of the protein in rat peripheral 
myelin (Wood & Dawson, 1973; Greenfield, Brostoff & Hogan, 1980). The Po 
protein is apparently only produced in significant levels by Schwann cells in 
association with the myelinated type of axon (Brockes, Fryxell & Lemke, 1981). 
It was more difficult to obtain monoclonal antibodies that served as markers for 
blastema! cells. In initial experiments, tissue homogenates or a crude membrane 
fraction were prepared from blastemas of forelimbs at the mid-bud stage of regen-
eration. Approximately 1000 antibody secreting clones were screened from seven 
animals immunized with this material. About 250 of these clones stained tissue 
sections of the regenerating limb but were found either to bind to extracellular 
matrix components present throughout the limb or to the epidermis, which was the 
major differentiatt::d tissue in the immunogen. In order to enrich for blastema! 
antigens, cells were mechanically dissociated from the blastema and partially 
purified by centrifugation through Ficoll gradients (see Materials and Methods). 
The hybridomas that arose from animals immunized with this material included 
two specificities of interest. One specificity, represented by 22/31, was relatively 
common (four examples). This class of antibody recognized antigens present in 
connective tissue fibroblasts in mature tissue and some blastema! cells in regen-
erating limbs. The second specificity, represented by a single clone 22/18, 
appeared not to stain tissue in the mature limb but stained cells in the blastema. 
Table 1. Isolation of monoclonal antibodies as cell markers 
Clones Representative Mr antigen 
Immunogen tested (A) No. specific clones x103 (B) 
Muscle 105 10 12/101 120 
Myelin 33 6 30/3 
30/14 
20-25 
Cartilage 121 7 
30/26 
10/58 ND 
Total Blastema 1000 0 
Blastema Cells 312 1 22/18 (C) 
4 22/31 51 
(A) The clones that were tested by immunofluorescence on tissue sections had first been 
scored as positive in an ELISA assay for mouse immunoglobulin (muscle, cartilage, or blastema! 
immunization) or for myelin (myelin immunization). 
(B) Relative molecular masses (Mr) of antigens recognized on immunoblots of crude hom-
oge.nate.s of muscle or blastema! tissue, or purified myelin after their separation in polyacryl-
amide gels containing sodium dodecyl sulphate and reducing agent as previously described (Fritz 
& Brockes, 1983). 
(C) Attempts to immunoblot the 22/18 antigen have been unsuccessful thus far. The staining 
of blastema! cells appears to be cytoplasmic and filamentous. ND: not tested. 
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22/31 and 22/18 were further characterized by staining a series of regenerating 
limbs at different stages, using several animals at each stage, and their properties 
are summarized in Table 2. 
Fig. 1. Staining of the normal limb with myofibre and myelin markers. Methacrylate 
sections were stained with a myofibre marker, 12/101, and a myelin marker, 30/26, as 
described in Materials and Methods. (A) A region of the limb containing muscle (left 
field) and the nerve sheath (right field) viewed under phase-contrast optics (bar= 
30 ~-tm) and (B) rhodamine optics to show staining of myofibres with 12/101. 
(C) Approximately the same region as in A and Bon an adjacent section viewed under 
phase-contrast optics (bar= 35 ,urn) and (D) rhodamine optics to show staining of the 
myelin sheaths with 30/26. 
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Expression of 22/31 and 22/18 in the regenerating limb 
It is important to note the standard conditions that were used for immuno-
fluorescence staining of tissue sections with 22/18 and 22/31. Purified monoclonal 
antibodies gave optimal staining when used at 5-10 f..lg ml- 1. Tissue was routinely 
fixed before sectioning by immersion in a periodate-lysine fixative. The binding of 
22/31 and 22/18 to tissue sections was detected as outlined in Table 2 and 
described in the Materials and Methods. Three points should be noted about these 
detection methods. Firstly, the use of three layers rather than two, considerably 
amplified the fluorescence signal for 22/18. Secondly, since 22/18 is an lgM 
antibody, it proved more sensitive to use a second antibody raised against IgM 
rather than one against IgG. Thirdly, 22/31 was conjugated with biotin and 
detected with fluoresceinated avidin because this method is one way that allows 
the separate detection of 22/31 and 22/18 (both IgM) on the same section. 
Fig. 2 diagram1natically summarizes 22/31 staining in the mature limb and at 
different stages of regeneration. 22/31 stains fibroblasts of connective tissue pres-
ent in dermis, muscle, perichrondrium and the nerve sheath in the mature limb 
(Fig. 2A). After amputation, most cells in the early-bud blastema do not stain with 
22/31 (Figs 2C and 3C). The subpopulation of cells that does stain is present at 
about the same density as in normal tissue and may therefore represent the 
contribution of connective tissue fibroblasts present before amputation. The area 
in the early-bud blastema that lies underneath and against the wound epidermis, 
however, is often a site where additional cells stain brightly with 22/31 (Fig. 
3D,E). As the blastema reaches the late-bud stage, the staining of cells in the 
blastema with 22/31 changes dramatically (Fig. 2D). Most, if not all, blastema! 
cells stain with 22/31 (Fig. 4A,C and D,F). This staining is most intense at the 
blastema tip and decreases proximally. Blastema! cells continue to stain with 22/31 
in this manner until differentiation in the blastema begins. As cells differentiate 
into cartilage, they lose 22/31 staining and chondrocytes express very low or 
undetectable levels of 22/31. In areas of muscle differentiation, the expression of 
22/31 appears to be lost even earlier (see below). 
Fig. 2 diagrammatically summarizes 22/18 staining in the mature limb and at 
different stages of regeneration. 22/18 does not stain cell types in sections of a 
mature limb with one exception. An intermittent punctate staining is sometimes 
Table 2. Properties of 22/18 and 22/31 
Hybridoma 
22/18 
Method of 
detection 
1st: Rabbit anti-
mouse IgM 
2nd: Rhodamine 
goat. anti-rab IgG 
22/31 FITC-Avidin 
(Biotinylated) 
Mature limb 
No detectable 
staining 
Fibroblasts in 
connective tissue 
Regenerating limb 
Early stage Later stage 
Majority of Minority of 
blastema! cells blastema! cells 
Minority of 
blastema! cells 
Majority of 
blastema! cells 
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Fig. 2. Schematic diagram of 22/18+ and 22/31 + cells in the mature and regenerating 
forelimb. The occurrence of 22/18+ cells (closed circles) and 22/31 +cells (open circles) 
in dermis, nerve, bone, muscle and the blastema in (A) an unamputated, mature limb, 
(B) a regenerating limb at wound healing, (C) a regenerating limb at the early- to 
medium-bud stage, or (D) a regenerating limb at the late-bud stage. 
observed within the nerve but it is not known if this staining is cellular. 22/18 
staining first appears at high levels four days after amputation on cells in the nerve 
sheath and to a lesser extent on scattered cells among muscle (Fig. 2B). As the 
early blastema forms and breakdown of mature tissue occurs more proximally, 
most blastema! cells among degenerating muscle, cartilage, and the nerve sheath 
stain with 22/18, as well as the majority of cells in the blastema itself (Figs 2C, 
3A,B). When the blastema grows into a bud, however, the 22/18 staining changes 
dramatically (Fig. 2D). At the base of the blastema, 22/18 staining is similar to 
early stages, but in the growing blastema, 22/18 stains only a subpopulation 
Fig. 3. 22/31 and 22/18 staining at early-bud stages. Tissue sections of an early-bud, 
forelimb blastema were stained with both 22/18 and 22/31 as described in Materials 
and Methods using techniques to separately detect 22/18 binding with rhodamine and 
22/31 binding with fluorescein. (A) A field in the middle of the blastema photographed 
under Nomarski optics, and (B) rhodamine optics to detect 22/18 staining or (C) 
fluorescein optics to detect 22/31 staining. Note that only a few cells stain with 22/31 
while a majority stain with 22/18. Furthermore, the 22/31 +cells do not stain, or stain 
very lightly, with 22/18. (D) A field in the tip of the blastema underneath the wound 
epidermis photographed with Nomarski optics, or (E) rhodamine optics to detect 
22/18 staining or (F) fluorescein optics to detect 22/31 staining. The left side of this 
field contains epidermis that does not stain with either antibody. Of the blastema! cells 
in this field, some stain with just 22/18, some with just 22/31 and some with both. 
Bar= S0 11m. 
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of cells (Fig. 4A,B and C,D). These 22/18 cells are present along the entire length 
of the blastema, tend to be clustered, and lie between the epidermis and the 
central core of the blastema. As blastema! cells differentiate into mature tissue, 
the 22/18 staining is lost. 
The staining of regenerating limbs at different stages with 22/31 and 22/18 
indicates that 22/18+ cells are predominant in the blastema at early stages ( 4 days 
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Fig. 4. 22/18 and 22/31 staining at late-bud stage. Lon~tudinal sections of a late-bud, 
forelimb blastema were stained with both 22/18 and 22/31 as described in the legend to 
Fig. 3. (A) A field at the tip of the blastema underneath the wound epidermis 
photographed with Nomarski optics, or (B) rhodamine optics to detect 22/18 staining 
or (C) fluorescein optics to detect 22/31 staining. Note that many of the blastema! cells 
stain with 22/31 while only a subpopulation stains with 22/18. (D),(E) and (F) A field 
in a tissue section of a different late-bud-stage blastema photographed in the same way 
as in A,B and C. Note that 22/18 only stains a subpopulation of blastema! cells and 
these cells (arrow in ~) are mainly 22/31 +. (Bars = 50 Jlm.) 
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after amputation until medium bud) while 22/31 + cells are predominant at later 
stages (after medium bud). By staining with double labels, it is possible to estimate 
the degree of overlap between these two populations. In early stages of 
regeneration when 22/18+ cells are predominant in the blastema, very few of the 
blastema! cells stain with both 22/18 and 22/31 (Fig. 3A-C). One exception is a 
population of cells underneath the wound epidermis at the most distal tip of the 
blastema which tend to stain with both 22/31 and 22/18. At late stages of 
regeneration when 22/31 +cells are predominant, almost all22/18+ cells outside of 
areas of cytodifferentiation also stain with 22/31 (Fig. 4). 
22/18 staining in the nerve sheath 
22/18 stains cells in the distal regions of the nerve sheath soon after amputation 
(Fig. 2B) and this staining of the nerve sheath increases in intensity and occurs 
more proximally as regeneration proceeds (Fig. 2C). From the appearance of the 
staining, it seemed likely that the 22/18 antigen is localized in Schwann cells of the 
nerve sheath after amputation. To examine this possibility, the expression of 22/18 
in the nerve sheath was compared with the expression of Po, the major protein of 
peripheral myelin and a marker associated with Schwann cell differentiation. 
Tissue sections of early-bud regenerates were stained with both 22/18 and 
monoclonal antibodies to newt Po (Table 1 and Fig. 1C,D) using a double-
labelling technique. In the most proximal regions of the regenerating limb, the 
nerve sheath stains intensely with the Po antibodies but not with 22/18. The nerve 
sheath in more distal regions of the limb stains at low levels with 22/18 in addition 
to the staining with Po antibodies. The 22/18 and Po staining of the intact nerve 
sheath is so dense, however, that it is difficult to determine if the antibodies are 
binding to the sarne or to separate cells. The nerve sheath is stained with the Po 
antibodies until the point at which it enters the blastema and breaks apart with the 
loss of the perineurium. These cells often stain with Po antibodies and, in some 
cases, also stain with 22/18 (Fig. SA-C). In the distal regions of the early blastema 
where most cells stain with 22/18, there is no staining with the Po antibodies. The 
simplest interpretation of these observations is that Schwann cells express 22/18 
when they dedifferentiate and divide but Schwann cells which have migrated from 
the nerve sheath into the blastema no longer express Po at detectable levels. It 
should be noted that cells staining for Po and 22/31 were not observed. 
22/18 is associated with myogenesis in late stages of regeneration 
22/18 stains only a subpopulation of blastema! cells at medium bud and later 
stages of regeneration. This subpopulation is present along the entire proxi-
mal-distal axis of the blastema but tends to be excluded from central regions of the 
blastema (Fig. 2D). The location of 22/18+ cells in the histologically undiffer-
entiated blastema corresponds to prospective areas of myogenesis, raising the 
possibility that cells expressing 22/18 are destined to form myotubes. To deter-
mine if 22/18- cells differentiate into muscle, palette-stage regenerates were 
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sectioned and stained with both 22/18 and a marker for myofibres, 12/101 
(Table 1, Fig. lA,B), using a double-labelling technique (Kintner & Brockes, 
Fig. 5. 22/18 and myelin staining in the early-bud stage. Longitudinal tissue sections of 
an early-bud, forelimb blastema were stained with both 22/18 and with 30/3, 30/14 and 
30/26. (A) A region of the limb between the blastema and mature tissue was 
photographed under Nomarski optics (bar= 20 !Jm), (B) fluorescein optics to detect 
the Po antibodies or (C) rhodamine optics to detect 22/18 staining. In this photograph, 
the nerve runs from mature tissue on the left to the blastema on the right. Note the 
presence of cells that stain with both 22/18 and the Po antibodies. 
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1984). The newly-forrned myotubes in the proximal regions of the blastema stain 
with the myofibre marker but not with 22/18 while cells in the distal and 
histologically undifferentiated regions of the blastema stain with 22/18 but not 
with 12/101. In regions of the blastema just distal to the newly formed myotubes, 
there are mononucleated cells that stain with the myofibre marker. Some of these 
cells also stain with 22/18 indicating that some 22/18+ cells differentiate into 
muscle. Cells which have fused to form myotubes do not appear to express 22/18. 
In cross section (Fig. 6), it is apparent that the regions staining with 22/18 
(Fig. 6B) correlate with regions that differentiate into muscle (Fig. 6C). In many 
of these regions, it is common to find cells that stain with both 12/101 and 22/18 
(Fig. 6E,F). 
Sections of palette-stage regenerates were also stained with both 22/31 and the 
myofibre marker. Mononucleated cells that expressed the myofibre antigen were 
detected just distal to newly formed myotubes. None of these cells, however, 
expressed 22/31 even though many 22/31 + cells were present in this region and 
were often adjacent to cells expressing the myofibre antigen. 
The effects of denervation on division of 22/ 18+ cells 
Denervation of regenerating limbs eliminates blastema! growth during early 
stages of regeneration. At about the late-bud stage, however, this growth becomes 
relatively nerve independent (Singer & Craven, 1948). The transition of the 
blastema from a nerve dependent to an independent stage correlates with the 
change in the proportion of 22/18+ cells in the blastema. This correlation is of 
consequence if cells that differ in 22/18 staining also differ in their dependence on 
the nerve for division. The relative labelling index of 22/18+ and 22/18- cells was 
determined in the presence and absence of the nerve at early and late stages of 
regeneration. Animals were bilaterally amputated, and then unilaterally dener-
vated at either 10 days after amputation when the blastema! growth is nerve 
dependent or at 20-25 days after amputation when it is relatively nerve inde-
pendent. The labelling index of cells in the blastema was determined 2 days after 
denervation by injection of PH]thymidine. 24 h after injection of label, forelimbs 
were fixed and processed for 22/18 staining and autoradiography as described in 
Materials and Methods. The labelling indices were calculated by counting the 
number of 22/18+ and 22/18- cells with labelled nuclei as well as total nuclei in 
four random fields from four different sections for each limb (1000 total nuclei/ 
limb). For each animal, the labelling indices of 22/18+ and 22/18- cells for the 
limb on the denervated side were divided by indices on the innervated side to give 
ratios which reflect the effect of denervation on division of 22/18+ and 22/18-
cells. The data are expressed in Table 3 as a mean± standard error of this ratio 
determined for four animals at an early time and eight animals at a late time. The 
percentage of labelled nuclei that stained with 22/18 was 75 ± 9% at early times 
and 27 ± 4% at late times. The results in Table 3 indicate that the labelling index 
of 22/18+ cells drops seven-fold upon denervation at either early or late stages 
while the labelling of 22/18- cells drops three-fold at early times and only 1·4-fold 
at late stages. It is apparent that 22/18+ cells remain nerve dependent for division 
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Fig. 6. 22/18 and myofibre staining in the palette-stage regenerate. Transverse tissue 
sections of a palette-stage regenerate were stained with both 22/18 and 12/101 as 
described in Materials and Methods. (A) A section of the regenerate containing a 
region of muscle differentiation was photographed under Nomarski optics (bar= 
50 Jim) with epidermis in the upper field and newly formed cartilage in the lower field. 
(B) Same region photographed with rhodamine optics to detect 22/18 staining and (C) 
fluorescein optics to detect 12/101 staining. Note that an area where 22/18 staining 
occurs is a site of 12/101 staining (large arrow). (D,E and F) are photographed under 
the same conditions but at a higher magnification (bar= 20 Jim). 
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at late stages of regeneration while the 22/18- cells may become progressively 
nerve independent. 
DISCUSSION 
Derivation of cell markers 
It has been relatively straightforward to obtain marker antibodies for myofibres, 
Schwann cells and cartilage, presumably because these differentiated cells express 
specific molecules at high levels as exemplified by the Po glycoprotein of per-
ipheral myelin. In contrast, it has been difficult to obtain antibodies that react with 
the undifferentiated blastema! cells but not with mature tissue. The 22/18 reagent 
was obtained only after screening about 1300 antibody-secreting clones (Table 1). 
It is probable that molecules characteristic of progenitor cells are present at lower 
levels than those that mark differentiated cells. In order to focus the immune 
response on progenitor cell antigens, it is therefore necessary to purify the cells 
away from extracellular matrix and differentiated cells. The regeneration blastema 
is one of the few examples in vertebrates where progenitor cells can be readily 
isolated in sufficient numbers to use as immunogen. 
The 22/18 cell marker 
The distribution of the 22/18 antigen in the limb at early stages of regeneration 
is quite striking, and invites some speculations about its significance. The antigen 
is not detectable in high levels in the normal limb, but appears locally in certain 
cell types that are in the process of dedifferentiation and is present in most of the 
blastema! cells during early stages of regeneration. It is not simply a marker for 
dividing cells, since quiescent cells in the blastema continue to express it (Table 3 
and unpublished observations), and dividing cells in other locations, such as the 
basal layer of the dermis, do not. It is not a universal marker for blastema! cells, 
even at earlier stages, as evidenced by the pattern of reactivity with the 22/31 
reagent that is discussed below. The time and location of 22/18 expression suggest 
rather that it identifies the appearance of a certain class of blastema! cell. It is 
important to note, however, than when forelimbs are denervated at the brachial 
plexus but not amputated, the antigen is expressed by the dedifferentiating 
Table 3. The labelling index of 22/18+ and 22/18- cells in the denervated versus 
innervated blastema 
Stage and time of 
denervation 
Early bud, 10 days 
(n = 4 newts) 
Palette, 25-30 days 
(n = 8 newts) 
Ratio of labelling indices in 
blastema (denervated/ innervated) 
Total cells 22/18+ cells 22/18- cells 
0·20 ± 0·03 0·13 ± 0·02 0·35 ± ·06 
0·52 ± 0·15 0·14 ± 0·03 0·77 ± 0·21 
Details of this experiment are given in the Materials and Methods section and the text. 
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Schwann cells during Wallerian degeneration. This is another context where cells 
revert from a differentiated state and are mobilized to divide (Bradley & Asbury, 
1970). 
Since 22/18 appears to be expressed when blastema! cells arise, it can be used to 
determine which cell types contribute to the blastema. In previous work (Kintner 
& Brockes, 1984), it was shown that 22/18 could be co-localized with a marker for 
myofibres on a small population of mononucleated cells in early stages of 
regeneration, and the properties of these cells supported the hypothesis that 
myofibres give rise to blastema! cells. In a similar approach, it is possible to detect 
cells in the nerve sheath that stain with both 22/18 and antibodies to Po, and it is 
likely therefore that Schwann cells give rise to blastema! cells. Schwann cells have 
been considered in several anatomical studies to contribute to the blastema 
(Guyenot & Schotte, 1926; Thornton, 1938; Trampusch & Harrebomee, 1965) and 
also in certain experimental cases where nerves appear to support regeneration of 
an irradiated blastema (Wallace, 1972; Maden, 1977). Thus, the use of22/18 along 
with markers for differentiated cells supports the anatomical studies which have 
concluded that the blastema is derived from several cell types in the limb 
(Thornton, 1938; Chalkley, 1954), and are contrary to the notion that connective 
tissue fibroblasts or undifferentiated progenitor cells are the exclusive source. The 
weakness of the present approach is that markers such as 12/101 or Po are 
probably lost quite rapidly on dedifferentiation (see Brockes, Fryxell & Lemke, 
1981), and hence it is not possible to determine how many blastema! cells are 
derived from a particular source. 
At later stages of regeneration, 22/18 marks a minority of the blastema! cells 
and the question arises as to their fate. It is possible that some of these cells may 
undergo myogenesis since their location in the blastema is characteristic of areas 
where this occurs (Iten & Bryant, 1973). More direct evidence for this possibility 
comes from the detection of cells that stain with both 22/18 and the myofibre 
marker 12/101. The possibility that 22/18 is an early marker for the myogenic 
lineage is interesting but requires further investigation. In view of the early 
contribution of the Schwann cells to the 22/18 population, it is appropriate to ask if 
some of these cells may later differentiate into Schwann cells. It is not known 
whether Schwann cells in regeneration arise from blastema! cells or if they migrate 
from the nerve sheath on ingrowth of the nerve. In either case, some of the 22/18+ 
cells at later stages could be cells that will enwrap the nerve axons and synthesize 
myelin. As in the case of the myogenic possibility, more discriminating markers 
and further studies are required to investigate this hypothesis. 
In summary, there is clearly no simple interpretation for the presence of the 
22/18 antigen. In the early stages, our previous studies and the present paper show 
that the antigen is clearly associated with dedifferentiation and the transition from 
muscle or Schwann cell to blastema! cell. In this sense it is perhaps more a 
marker of cell 'state' than of a particular blastema! cell type or lineage. In the later 
stages, by contrast, the restriction of the antigen to blastema! cells in a particular 
and suggestive location is more indicative of a marker of lineage. At both times, 
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nonetheless, it identifies cells whose proliferation is dependent on the nerve. 
Despite these uncertainties, the antigen has provided new information about 
blastema! cells and further studies of its significance are warranted. 
22/31 and the changing composition of the blastema 
In the normal limb, antibody 22/31 stains fibroblasts in the dermis, as well as in 
muscle and nerve. It is appropriate to ask if the 22/31 population in the blastema at 
different stages is derived wholly or in part from division of the 'resident' 
population present in the dermis around the blastema, or in muscle and nerve, but 
we have no rigorous information to answer this important question. Thus 22/31 
was not expressed in conjunction with either of the markers (Po or 12/101) for 
differential cells. A number of investigators have stressed the importance of the 
dermal contribution for patterning in the blastema (Carlson, 1974; Bryant, 1978; 
Settles, 1978; Slack, 1980; Tank, 1981), and the 22/31 cells present in this location 
are clearly deserving of further study. 
The pattern of staining with 22/18 and 22/31 indicates that the cellular 
composition of the blastema changes during regeneration. During early stages, 
22/18 stains a majority of cells while 22/31 stains a minority and the two 
populations do not overlap. At later stages, but before the onset of significant 
cytodifferentiation in the blastema, the proportions are reversed and double-
labelled cells are present. The importance of this change in cellular composition 
was examined for the issue of nerve-dependent growth, since it has been shown 
that denervation has a profound effect on growth at early stages, and much less 
effect at later stages (Singer & Craven, 1948). The results (Table 3) indicate that 
the division of 22/18+ cells is nerve dependent at both stages while the division of 
22/18- cells is much less so. Since the proportion of 22/18+ cells is less at later 
stages, the change in cell composition is part of the explanation for the different 
consequences of denervation. It is of interest that 22/18 identifies a population 
that retains dependence on the nerve for division even at late stages when tissue 
pattern emerges and indeed retains an identical quantitative dependence to that 
shown at earlier stages. This insight would be very difficult to obtain without cell 
markers. One prediction of these considerations (Brockes, 1984) is that the 
regenerate would be nerve independent for growth if 22/18+ cells were replaced 
with 22/18- cells at earlier stages. This situation may exist in aneurogenic limbs 
(Yntema, 1959) and could therefore be the basis of nerve-independent regen-
eration - a possibility that can be readily tested with the available antibodies. 
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